TWST logo

Twist Bioscience (TWST) EBITDA

annual EBITDA:

-$176.71M-$2.55M(-1.47%)
September 30, 2024

Summary

  • As of today (June 22, 2025), TWST annual EBITDA is -$176.71 million, with the most recent change of -$2.55 million (-1.47%) on September 30, 2024.
  • During the last 3 years, TWST annual EBITDA has fallen by -$32.79 million (-22.79%).
  • TWST annual EBITDA is now -351.78% below its all-time high of -$39.11 million, reached on September 30, 2016.

Performance

TWST EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTincome statement metrics

quarterly EBITDA:

-$32.61M-$7.51M(-29.94%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TWST quarterly EBITDA is -$32.61 million, with the most recent change of -$7.51 million (-29.94%) on March 31, 2025.
  • Over the past year, TWST quarterly EBITDA has increased by +$4.24 million (+11.50%).
  • TWST quarterly EBITDA is now -115.96% below its all-time high of -$15.10 million, reached on March 31, 2018.

Performance

TWST quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTincome statement metrics

TTM EBITDA:

-$162.84M+$4.24M(+2.54%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TWST TTM EBITDA is -$162.84 million, with the most recent change of +$4.24 million (+2.54%) on March 31, 2025.
  • Over the past year, TWST TTM EBITDA has dropped by -$5.04 million (-3.19%).
  • TWST TTM EBITDA is now -957.77% below its all-time high of -$15.39 million, reached on September 30, 2017.

Performance

TWST TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

TWST EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.5%+11.5%-3.2%
3 y3 years-22.8%+42.6%+13.2%
5 y5 years-76.8%-8.9%-17.1%

TWST EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.8%+16.5%-29.9%+57.7%-3.2%+23.1%
5 y5-year-76.8%+16.5%-48.0%+57.7%-49.6%+23.1%
alltimeall time-351.8%+16.5%-116.0%+57.7%-957.8%+23.1%

TWST EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$32.61M(+29.9%)
-$162.84M(-2.5%)
Dec 2024
-
-$25.09M(-10.6%)
-$167.08M(-5.4%)
Sep 2024
-$176.71M(+1.5%)
-$28.07M(-63.6%)
-$176.71M(-5.3%)
Jun 2024
-
-$77.08M(+109.2%)
-$186.60M(+18.2%)
Mar 2024
-
-$36.84M(+6.1%)
-$157.81M(-8.5%)
Dec 2023
-
-$34.72M(-8.6%)
-$172.41M(-1.0%)
Sep 2023
-$174.15M(-17.7%)
-$37.96M(-21.4%)
-$174.15M(-4.3%)
Jun 2023
-
-$48.28M(-6.2%)
-$182.03M(-4.2%)
Mar 2023
-
-$51.45M(+41.1%)
-$189.97M(-2.7%)
Dec 2022
-
-$36.45M(-20.5%)
-$195.34M(-7.7%)
Sep 2022
-$211.68M(+47.1%)
-$45.84M(-18.5%)
-$211.68M(+3.7%)
Jun 2022
-
-$56.22M(-1.1%)
-$204.22M(+8.9%)
Mar 2022
-
-$56.82M(+7.6%)
-$187.60M(+13.0%)
Dec 2021
-
-$52.79M(+37.5%)
-$166.08M(+15.4%)
Sep 2021
-$143.91M
-$38.39M(-3.1%)
-$143.91M(+12.8%)
Jun 2021
-
-$39.60M(+12.2%)
-$127.55M(+11.7%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$35.30M(+15.3%)
-$114.23M(+4.9%)
Dec 2020
-
-$30.63M(+39.1%)
-$108.86M(-17.6%)
Sep 2020
-$132.09M(+32.1%)
-$22.02M(-16.2%)
-$132.09M(-5.2%)
Jun 2020
-
-$26.28M(-12.2%)
-$139.35M(+0.2%)
Mar 2020
-
-$29.93M(-44.4%)
-$139.03M(+4.5%)
Dec 2019
-
-$53.85M(+83.8%)
-$133.04M(+33.1%)
Sep 2019
-$99.97M(+56.3%)
-$29.29M(+12.8%)
-$99.97M(+12.7%)
Jun 2019
-
-$25.96M(+8.4%)
-$88.69M(+13.3%)
Mar 2019
-
-$23.95M(+15.3%)
-$78.25M(+12.7%)
Dec 2018
-
-$20.78M(+15.4%)
-$69.40M(+8.5%)
Sep 2018
-$63.95M(+20.4%)
-$18.01M(+16.1%)
-$63.95M(+4.3%)
Jun 2018
-
-$15.52M(+2.8%)
-$61.34M(+33.9%)
Mar 2018
-
-$15.10M(-1.5%)
-$45.82M(+49.1%)
Dec 2017
-
-$15.33M(-0.4%)
-$30.72M(+99.6%)
Sep 2017
-$53.10M(+35.8%)
-$15.39M
-$15.39M
Sep 2016
-$39.11M
-
-

FAQ

  • What is Twist Bioscience annual EBITDA?
  • What is the all time high annual EBITDA for Twist Bioscience?
  • What is Twist Bioscience annual EBITDA year-on-year change?
  • What is Twist Bioscience quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Twist Bioscience?
  • What is Twist Bioscience quarterly EBITDA year-on-year change?
  • What is Twist Bioscience TTM EBITDA?
  • What is the all time high TTM EBITDA for Twist Bioscience?
  • What is Twist Bioscience TTM EBITDA year-on-year change?

What is Twist Bioscience annual EBITDA?

The current annual EBITDA of TWST is -$176.71M

What is the all time high annual EBITDA for Twist Bioscience?

Twist Bioscience all-time high annual EBITDA is -$39.11M

What is Twist Bioscience annual EBITDA year-on-year change?

Over the past year, TWST annual EBITDA has changed by -$2.55M (-1.47%)

What is Twist Bioscience quarterly EBITDA?

The current quarterly EBITDA of TWST is -$32.61M

What is the all time high quarterly EBITDA for Twist Bioscience?

Twist Bioscience all-time high quarterly EBITDA is -$15.10M

What is Twist Bioscience quarterly EBITDA year-on-year change?

Over the past year, TWST quarterly EBITDA has changed by +$4.24M (+11.50%)

What is Twist Bioscience TTM EBITDA?

The current TTM EBITDA of TWST is -$162.84M

What is the all time high TTM EBITDA for Twist Bioscience?

Twist Bioscience all-time high TTM EBITDA is -$15.39M

What is Twist Bioscience TTM EBITDA year-on-year change?

Over the past year, TWST TTM EBITDA has changed by -$5.04M (-3.19%)
On this page